Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadian IL-6 and timed-release prednisone in polymyalgia rheumatica
2008-007315-32Phase 4Unknown
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisone in polymyalgia rheumatica (PMR) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Circadian variation in serum IL-6. Status: unknown.
02
Drugs
prednisone
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2008-007315-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007315-32.